DEF: Delcath Systems Seeks Stockholder Approval for Equity Incentive Plan Amendments at 2025 Annual Meeting

Delcath Systems is asking stockholders to approve amendments to its equity incentive and employee stock purchase plans at the upcoming annual meeting to enhance its ability to attract and retain key personnel.

Summary

• Delcath Systems, Inc. has announced its 2025 Annual Meeting of Stockholders to be held virtually on May 15, 2025.
• Stockholders will vote on several proposals, including the election of two Class I directors, amendments to the 2020 Omnibus Equity Incentive Plan and the 2021 Employee Stock Purchase Plan, ratification of the selection of CBIZ CPAs as the independent registered public accounting firm, and an advisory vote on executive compensation.
• The company seeks to increase the number of shares available under the 2020 Omnibus Equity Incentive Plan by 2,200,000 and under the 2021 Employee Stock Purchase Plan by 300,000.
• These amendments are intended to provide sufficient equity compensation to attract, retain, and motivate employees, non-employee directors, and consultants.
• The Board of Directors recommends voting FOR all proposals.

Sentiment

Score: 7

Explanation: The document is neutral in tone, presenting standard corporate governance matters. The proposed equity plan amendments suggest a positive outlook for growth and talent acquisition.

Positives

• The proposed amendments to the equity incentive plans aim to attract, retain, and motivate qualified personnel.
• Equity compensation aligns the interests of employees, non-employee directors, and consultants with stockholder interests.
• The company is taking steps to ensure good corporate governance by seeking stockholder ratification of the independent accounting firm selection.
• The company is actively managing its capital structure and equity compensation practices.

Negatives

• The company has a large number of outstanding in-the-money warrants and convertible preferred shares, which results in a capital structure that has approximately 38,173,223 shares of Common Stock and Common Stock equivalents outstanding.
• If the stockholders do not approve the 2020 Plan Amendment, the company will be limited in its ability to continue to issue awards under the 2020 Plan in numbers sufficient to attract and motivate the highly skilled employees it needs to recruit and retain.

Risks

• Failure to secure stockholder approval for the proposed amendments could hinder the company's ability to attract and retain talent.
• The company's actual usage of stock plan shares for employee awards under the 2020 Plan (and the 2020 Plan Amendment) will be impacted by changes in the number and level of our employees, the type of equity awards we grant, our potential growth and activities, the financial impact of grants and financing activities, as well as other factors, such as industry performance and general business, economic, regulatory, market and financial conditions.
• The unpredictability of the underlying assumptions and estimates could impact the level of total shares outstanding and utilization of equity awards.

Future Outlook

The company aims to continue offering effective equity compensation to attract and retain qualified personnel and to take advantage of the significant motivation and retention benefits provided by equity compensation.

Industry Context

In the competitive life sciences industry, equity compensation is a critical element of attracting and retaining highly skilled people.

Comparison to Industry Standards

• The analysis conducted by our compensation consultant Frederick W. Cook & Co., Inc. (FW Cook), which looked to manage annual share spend, total overhang levels and competitive market grant practices in an appropriate manner.
• The analysis considered that we have a large number of outstanding in-the-money warrants and convertible preferred shares, which results in a capital structure that has approximately 38,173,223 shares of Common Stock and Common Stock equivalents outstanding.
• The proposed reservation of an additional 2,200,000 shares under the 2020 Plan Amendment is most appropriately considered as less than six percent (6.0%) of the totality of common share equivalents with the in-the-money warrants and convertible preferred shares included.
• Taking into account our hiring plans over that period, we believe that our burn rate will be approximately six percent (6.0%) if awards are granted as stock options; the Board believes that a burn rate of approximately six percent (6.0%) is a reasonable burn rate.

Stakeholder Impact

• Approval of the equity incentive plan amendments could positively impact employees, non-employee directors, and consultants by providing them with long-term incentive compensation opportunities.
• Stockholders could benefit from the company's enhanced ability to attract and retain key personnel, potentially leading to improved company performance and increased stockholder value.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on May 15, 2025.
• The company will file the final certified results of the voting in a Current Report on Form 8-K within four business days after the Annual Meeting.

Key Dates

Keywords

equity incentive plan, stock purchase plan, annual meeting, proxy statement, Delcath Systems, executive compensation, directors, shares, stockholders, amendment